Atazanavir + cobicistat (Evotaz)
- Status:
- Red
- Decision Date:
- November 2021
Comments
RED: Use in combination with other antiretroviral medicinal products for the treatment of HIV-1 infected adults and adolescents (aged ≥12 years weighing ≥35 kg) without known mutations associated with resistance to atazanavir.
Red Drug Classifications
- 8. NHS England commissioned – to be used in line with NHSE commissioning intentions
search again